Antibiotic recalled after cardboard particles found in solution
Baxter has recalled a specific lot an injectable antibiotic due to the presence of particular matter in the solution. Testing the foreign particles confirmed that they are cardboard.
What is being recalled?
The recall covers lot LD175708 of Baxter’s Cefazolin in Dextrose Injection. This antibiotic is used intravenously to treat bacterial infections or help prevent such infections after surgery.
The recalled bags were distributed throughout the United States from March 25 to June 30, 2025. They are set to expire in February 2027.
No other lots should be impacted by this advisory.
Customers should check their inventories for the lot number in question. Image courtesy of Baxter and the FDA.
Why did Baxter initiate this recall?
According to Baxter, using any of the recall solutions to treat patients could result in one of several cardiovascular complications.
“The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting),” according to the company’s announcement, which was also shared by the U.S. Food and Drug Administration (FDA). Systemically, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis.
The recall covers lot LD175708 of Baxter’s Cefazolin in Dextrose Injection. These bags were distributed throughout the United States from March 25 to June 30, 2025. They are set to expire in February 2027.
Click here for more from the Baxter and the FDA.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.